InMed amends Armistice option exercise price from $16.60 to $0.80 per share

InMed Pharmaceuticals Inc.

Up to 278,761 common shares subject to options; exercise price reduced to $0.80 from $16.60.
Options originally issued October 26, 2023; amendment entered May 18, 2026.
Dramatic price reduction may increase dilution risk for existing shareholders if exercised.
Press release issued May 19, 2026 confirms amendment; no assurance options will be exercised.

item 1.01item 3.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.